標(biāo)題: Titlebook: Blood and Marrow Transplant Handbook; Comprehensive Guide Richard T. Maziarz,Susan Schubach Slater Book 20152nd edition Springer Science+B [打印本頁] 作者: quick-relievers 時間: 2025-3-21 19:45
書目名稱Blood and Marrow Transplant Handbook影響因子(影響力)
書目名稱Blood and Marrow Transplant Handbook影響因子(影響力)學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook網(wǎng)絡(luò)公開度
書目名稱Blood and Marrow Transplant Handbook網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook被引頻次
書目名稱Blood and Marrow Transplant Handbook被引頻次學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook年度引用
書目名稱Blood and Marrow Transplant Handbook年度引用學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook讀者反饋
書目名稱Blood and Marrow Transplant Handbook讀者反饋學(xué)科排名
作者: minimal 時間: 2025-3-21 20:15 作者: ANTI 時間: 2025-3-22 02:19
https://doi.org/10.1007/978-0-387-68238-9se of corticosteroids and other medications. Hypogammaglobulinemia and functional asplenia are common. The occurrence of infections in an individual patient varies according to the phase of the transplant process and reflects the type(s) of immune defect(s), underlying disease, endogenous host flora, exposure history, and pretreatment infections.作者: 消毒 時間: 2025-3-22 08:05 作者: 商業(yè)上 時間: 2025-3-22 11:08
Chemistry of Photocurable Compositions,ctions in an individual patient varies according to the phase of the transplant process and reflects the type(s) of immune defect(s), underlying disease, endogenous host flora, exposure history, and pre-treatment infections.作者: 挫敗 時間: 2025-3-22 16:55
Pre-transplant Medical Evaluationipient..Referral to a transplant center does not mandate a patient to undergo a transplant procedure. It is the role of the HSCT specialist to determine if transplant should be considered as an option for disease consolidation with final decision to be made in conjunction with the patient and the referral provider team.作者: Instantaneous 時間: 2025-3-22 19:40 作者: 宣誓書 時間: 2025-3-22 23:57
Infection Prophylaxisse of corticosteroids and other medications. Hypogammaglobulinemia and functional asplenia are common. The occurrence of infections in an individual patient varies according to the phase of the transplant process and reflects the type(s) of immune defect(s), underlying disease, endogenous host flora, exposure history, and pretreatment infections.作者: incisive 時間: 2025-3-23 02:47 作者: Chronic 時間: 2025-3-23 08:55
Infectious Complicationsctions in an individual patient varies according to the phase of the transplant process and reflects the type(s) of immune defect(s), underlying disease, endogenous host flora, exposure history, and pre-treatment infections.作者: Vo2-Max 時間: 2025-3-23 12:46 作者: novelty 時間: 2025-3-23 14:37 作者: Aqueous-Humor 時間: 2025-3-23 22:01 作者: foliage 時間: 2025-3-23 23:34 作者: 凌辱 時間: 2025-3-24 03:18 作者: saturated-fat 時間: 2025-3-24 10:13 作者: 向外 時間: 2025-3-24 11:51 作者: Emasculate 時間: 2025-3-24 15:30
Physical and Occupational Therapy of loss of strength, cancer-related fatigue, loss of cognitive functioning, and decreased quality of life. Rehabilitation services, primarily occupational and physical therapies, are beneficial members of the treatment team and are able to assist with return of function using a variety of techniques including engagement in physical activity.作者: corpus-callosum 時間: 2025-3-24 19:16 作者: gain631 時間: 2025-3-25 03:02
Radiology Pearls for the Transplant Providere in detection and monitoring of post-transplant abnormalities. This chapter reviews imaging appearance of some of the most frequently encountered post-transplant pulmonary and abdominal complications.作者: 萬神殿 時間: 2025-3-25 05:30
Book 20152nd editionasy-to-use, .Blood and Marrow Transplant Handbook, 2nd Edition. presents a multidisciplinary approach to information for physicians and advanced practice medical providers who care for transplant patients, and also residents, fellows, and other trainees..作者: 合乎習(xí)俗 時間: 2025-3-25 09:00 作者: 不容置疑 時間: 2025-3-25 15:35 作者: 漫不經(jīng)心 時間: 2025-3-25 18:25 作者: dominant 時間: 2025-3-25 20:58
Graft-Versus-Host Disease Prophylaxist inflammation, and regulate donor T cell quantity and type. This chapter focuses on standard management, new approaches, and future directions of GVHD prophylaxis, as they relate to conditioning regimens, donor T cell manipulation, and posttransplant medication management.作者: 人工制品 時間: 2025-3-26 03:51
Overview of Hematopoietic Stem Cell Transplantation a significant morbidity and mortality substantiating the continued need for ongoing research. There are many areas of active research encompassing all phases of the transplant procedure. However, with the advancements in technology comes challenges including workforce shortages and challenge in pro作者: acquisition 時間: 2025-3-26 08:03 作者: 短程旅游 時間: 2025-3-26 10:31
Hematopoietic Stem Cell Sources and Donor Selectionensive donor workup and stem cell procurement, and lower rates of acute and chronic graft versus host disease. However, only 30?% of patients who require an allogeneic HSCT will have a suitable matched related donor. Identification of an appropriate matched unrelated donor can take 2–6 months and ma作者: 灰心喪氣 時間: 2025-3-26 16:13 作者: growth-factor 時間: 2025-3-26 18:42
for long-term follow up care. Concise, comprehensive, and easy-to-use, .Blood and Marrow Transplant Handbook, 2nd Edition. presents a multidisciplinary approach to information for physicians and advanced practice medical providers who care for transplant patients, and also residents, fellows, and other trainees..978-3-319-13832-9作者: maculated 時間: 2025-3-26 23:51 作者: 瑣碎 時間: 2025-3-27 03:55 作者: 聰明 時間: 2025-3-27 07:14 作者: 短程旅游 時間: 2025-3-27 12:38 作者: MULTI 時間: 2025-3-27 17:15
Overview of Hematopoietic Stem Cell Transplantationwhere no other curative treatment options exist. The key element in HSCT is the replacement of the host (recipient) marrow function by another source of hematopoietic stem cells (HSC), from either the patient or a human leukocyte antigen (HLA)-compatible family member or unrelated donor. In the sett作者: Commodious 時間: 2025-3-27 19:57
The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantationtient/family resources. As indications for transplantation multiplied and transplant-related mortality declined, HSCT utilization expanded with a dramatic increase in the number of both autologous and allogeneic procedures performed over the past decade..HSCT has demonstrated efficacy for the treatm作者: AROMA 時間: 2025-3-28 00:40 作者: 令人悲傷 時間: 2025-3-28 04:02 作者: 繼承人 時間: 2025-3-28 09:55
Social Work: Evaluation and Supportand stresses patient’s coping strategies. The course of treatment and its recovery can span over months to years, stretching these patients’ and support persons’ psychosocial capabilities to their limits and beyond. The stages of this process have unique aspects that need understanding and attention作者: CRAFT 時間: 2025-3-28 13:39 作者: 廚房里面 時間: 2025-3-28 16:45 作者: 異端 時間: 2025-3-28 20:35 作者: Indent 時間: 2025-3-28 23:44
Adolescent and Young Adult Concernsd between the worlds of pediatric and adult oncology. This group of individuals is now identified in clinical trials and in clinical care as the adolescent and young adult (AYA) population. Historically, hematopoietic stem cell transplant (HSCT) has been applied selectively to younger, healthier pat作者: 不可救藥 時間: 2025-3-29 05:30 作者: Bumptious 時間: 2025-3-29 07:34 作者: 去世 時間: 2025-3-29 14:27 作者: 宇宙你 時間: 2025-3-29 15:48 作者: EWER 時間: 2025-3-29 19:57
Follow-Up Careogeneic (related and unrelated), nonmyeloablative, and cord blood transplants. It is meant as a guideline in setting up frequency of follow-up with providers, suggested laboratories, and supportive care. Also addressed are recommendations for increasing activity and addressing activities of daily li作者: rectocele 時間: 2025-3-30 03:36
Radiology Pearls for the Transplant Providerabnormality developed post HSCT depends on the type of transplant, conditioning regimen, and time-elapsed post transplant. Imaging plays a crucial role in detection and monitoring of post-transplant abnormalities. This chapter reviews imaging appearance of some of the most frequently encountered pos作者: amphibian 時間: 2025-3-30 06:38
Infectious Complicationshemotherapy, radiation therapy), mucosal damage, type of transplant, immune suppressive therapy, and graft-versus-host disease (GVHD) all predispose the HSCT recipient to infection. Abnormal B- and T-lymphocyte function results in impaired humoral and cellular immunity, respectively. Neutrophil func作者: 蓋他為秘密 時間: 2025-3-30 09:57
Special Techniques of Illuminationwhere no other curative treatment options exist. The key element in HSCT is the replacement of the host (recipient) marrow function by another source of hematopoietic stem cells (HSC), from either the patient or a human leukocyte antigen (HLA)-compatible family member or unrelated donor. In the sett作者: 象形文字 時間: 2025-3-30 13:39
Some Essentials of Geometrical Opticstient/family resources. As indications for transplantation multiplied and transplant-related mortality declined, HSCT utilization expanded with a dramatic increase in the number of both autologous and allogeneic procedures performed over the past decade..HSCT has demonstrated efficacy for the treatm作者: Visual-Acuity 時間: 2025-3-30 20:12 作者: 不遵守 時間: 2025-3-30 23:22
https://doi.org/10.1007/978-94-009-4672-9ith significant risk for noninfectious and infectious complications. Reduced intensity allogeneic HSCT is often offered to recipients with advanced age and/or significant comorbid clinical conditions. Appropriate identification of recipients likely to benefit from these rigorous procedures is essent作者: 看法等 時間: 2025-3-31 03:40
A Statistical Analysis of the LRS Catalogand stresses patient’s coping strategies. The course of treatment and its recovery can span over months to years, stretching these patients’ and support persons’ psychosocial capabilities to their limits and beyond. The stages of this process have unique aspects that need understanding and attention作者: Ischemia 時間: 2025-3-31 05:21 作者: 內(nèi)行 時間: 2025-3-31 12:55
Astrophysics and Space Science Libraryrelated to their disease process and conditioning regimen toxicities. Complications of graft-versus-host disease (GVHD) and infectious events also lead to increased metabolic demands. The patient’s pre- and post-transplant nutritional status, pre-transplant comorbidities, and posttransplant complica
